Document is current
Any future updates will be listed below
-
Authors
Sombié, Olivier O.
Zeba, Augustin N.
Somé, Jérome W.
Kazienga, Adama
David, Christopher R.
Granh, Michael
De Henauw, Stefaan
Tanumihardjo, Sherry A.
Abbeddou, Souheila
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 6 January 2026
First Online: 10 January 2026
Declarations
:
: Prior to data collection, the study protocol was submitted to and approved by the Institutional Review Board of the Institut de Recherche en Sciences de la Santé (IRSS), a locally based research institution in Burkina Faso (approval N˚11-2016/CEIRES). In addition, authorization to implement the study was obtained from the Haut-Bassin Regional Health Directorate, Burkina Faso (N˚2016 E0202/MS/RHBS/DRS). Study personnel were trained in the principles of good clinical and laboratory practices. Written informed consent was obtained from caregivers for both their participation and the collection of biological samples from their children. Data collection was conducted in accordance with the principles outlined in the Declaration of Helsinki. Additionally, the study was retrospectively registered as a clinical trial on March 22, 2018, with the Pan African Clinical Trials Registry (Cochrane South Africa; PACTR201803002999356).
: Not applicable.
: The authors declare no competing interests.
